Immediately after the WSJ report was published, Ms. Holmes declined the accusations in an extensive interview with CNBC and at The Wall Street Journal tech conference in Laguna Beach, California. Ms. Holmes repeated over and over again that the article was false and declined each of the accusations raised there. However, the company refused to reveal more information about its technology and diagnostic process. Not going into the entire discussion of whether Theranos has misled investors and customers, but looking at the entire private placing market – I believe that this is a red flag. When a respectable newspaper publishes such thorough and comprehensive research...